Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Osteosarcoma × endostar protein × Clear all

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 4 Esophageal Squamous Cell Carcinoma 2 Uterine Cervical Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Pleural Effusion, Malignant 1 Osteosarcoma 1 Nasopharyngeal Neoplasms 1 Nasopharyngeal Carcinoma 1 Carcinoma, Hepatocellular 1 Bone Neoplasms 1 Advanced Gastric Cancer 1

Interventions

Methotrexate 16 Ifosfamide 16 Doxorubicin 13 Filgrastim 11 Etoposide 11 Cisplatin 11 Cyclophosphamide 9 Leucovorin 7 Gemcitabine 7 Sirolimus 6 Irinotecan 5 Granulocyte Colony-Stimulating Factor 5 Carboplatin 5 Topotecan 4 Temozolomide 4 Sorafenib 4 Radiotherapy 4 Docetaxel 4 trimetrexate glucuronate 3 temsirolimus 3 dinutuximab 3 cixutumumab 3 Vincristine 3 Peripheral Blood Stem Cell Transplantation 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Imatinib Mesylate 3 tanespimycin 2 sargramostim 2 pegfilgrastim 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06562673 2025-12-29

IACE-OS

Shanghai 6th People's Hospital

Phase 1/2 Completed

Bone Neoplasms, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡